|
|
Azopt is an eye-drop medication used to lower intraocular pressure in patients with glaucoma or ocular hypertension by reducing the production of fluid in the eye.
|
|
1%
1bottle |
|
$85.19
$70.99 $70.99 per bottle |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $0.00 |
|
|
+ Package delivery insurance + Next orders 10% discount |
|||||
|
1%
2bottles |
|
$142.79
$118.99 $59.49 per bottle |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $23.00 |
|
|
+ Package delivery insurance + Next orders 10% discount |
|||||
|
1%
3bottles |
|
$176.39
$146.99 $49.00 per bottle |
+ Package delivery insurance + Next orders 10% discount |
ADD TO CART save: $65.97 |
|
|
+ Package delivery insurance + Next orders 10% discount |
|||||
October
![]() |
|
Delivery period 14-21 days |
14.95$ | Tracking# available in 4 days |
![]() |
|
Delivery period 9-14 days |
30$ | Tracking# available in 2 days |
Common use
Azopt (brinzolamide) is a prescription ophthalmic suspension used for the treatment of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. When you buy Azopt online, you receive a topical carbonic anhydrase inhibitor (CAI) that works by selectively inhibiting carbonic anhydrase II in the ciliary processes of the eye, reducing the production of aqueous humor and effectively lowering intraocular pressure. By decreasing IOP, Azopt helps prevent progressive damage to the optic nerve and preserves visual field, making it an essential component of glaucoma management strategies. Azopt can be used as monotherapy or as adjunctive therapy alongside other IOP-lowering medications such as beta-blockers, prostaglandin analogues, or alpha-adrenergic agonists.
Dosage and direction
Azopt brinzolamide ophthalmic suspension (1%) is typically instilled as one drop into the affected eye(s) two to three times daily, or as directed by your ophthalmologist. Before each use, shake the bottle well to ensure uniform suspension. To apply, tilt your head back, gently pull down the lower eyelid to create a conjunctival pocket, and instill one drop into the pocket. Close your eye gently for one to two minutes and apply gentle pressure to the nasolacrimal duct (inner corner of the eye) to minimize systemic absorption. Avoid touching the dropper tip to your eye, eyelids, fingers, or any other surface to prevent contamination. If using multiple ophthalmic medications, wait at least 10 minutes between applications to allow proper absorption of each product.
Precautions
Before using Azopt eye drops, inform your ophthalmologist if you have kidney disease or renal impairment, liver problems, a history of eye infections or corneal disorders, or any known allergy to sulfonamide medications, as brinzolamide is a sulfonamide derivative and cross-sensitivity reactions may occur. Patients with severe renal impairment should avoid Azopt due to reduced drug clearance. Remove contact lenses before instilling Azopt and wait at least 15 minutes before reinserting them, as the preservative benzalkonium chloride may be absorbed by soft contact lenses. Report any signs of eye infection, increased redness, pain, or vision changes to your eye doctor promptly.
Contraindications
Do not use Azopt if you have a known allergy to brinzolamide, other sulfonamides, or any component of the ophthalmic suspension. Azopt is contraindicated in patients with severe renal impairment (creatinine clearance below 30 mL/min) and in patients with hyperchloremic acidosis.
Possible side effect
Common side effects of Azopt brinzolamide eye drops include temporary blurred vision immediately after instillation, mild eye burning or stinging, a bitter or unusual taste in the mouth, eye discomfort, dry eyes, foreign body sensation, and mild eye redness. These effects are usually transient and diminish with continued use. Less common but more serious side effects may include allergic conjunctivitis, corneal edema, eye swelling or pain, dermatitis, Stevens-Johnson syndrome, or signs of systemic sulfonamide reaction. Seek immediate medical attention if you experience severe eye pain, sudden vision changes, swelling of the face or throat, or difficulty breathing.
Drug interaction
Azopt may interact with other carbonic anhydrase inhibitors (such as oral acetazolamide or dorzolamide), potentially leading to additive systemic effects including metabolic acidosis and electrolyte disturbances. Use caution when combining with high-dose aspirin therapy, as salicylates may enhance the systemic toxicity of carbonic anhydrase inhibitors. Medications affecting kidney function should be used with caution. Inform your doctor about all prescription drugs, over-the-counter products, eye drops, and supplements you are taking to ensure safe combination therapy.
Missed dose
If you miss a dose of Azopt, apply it as soon as you remember and continue with your regular dosing schedule. If it is almost time for the next dose, skip the missed application and proceed as normal. Do not apply a double dose to make up for the missed one.
Overdose
Topical overdose of Azopt eye drops may cause temporary eye irritation, excessive tearing, or blurred vision. If excessive amounts are accidentally ingested or absorbed systemically, symptoms may include electrolyte imbalances, metabolic acidosis, or central nervous system effects. Seek medical attention promptly if overdose is suspected, and flush the eyes thoroughly with clean water if excessive drops have been applied.
Storage
Store Azopt ophthalmic suspension at controlled room temperature between 4 and 30 degrees Celsius (39-86 degrees Fahrenheit), away from excessive heat and direct light. Keep the bottle tightly closed when not in use and store upright and out of reach of children. Do not freeze. Discard any unused suspension after the timeframe specified by your pharmacist or as indicated on the label after first opening.
Disclaimer
We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.

2

